Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lecia Sequist, MD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Yale Comprehensive Cancer Center
New Haven, Connecticut, United States
- Mount Sinai Comprehensive Cancer Center
Miami, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Mary Crowley Cancer Research Centers - Baylor
Dallas, Texas, United States
- Mary Crowley Cancer Research Centers - Medical City
Dallas, Texas, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2007
- Primary completion
- 31 Aug 2011
- Completion
- 31 Dec 2011
- Last update posted
- 10 Dec 2012
- Registered enrollment
- 88
- Registry id
- NCT00431015
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.